from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2272/-

LFCtreatmentdescriptionclass of inhibitor

-0.484

Amikacinug/mL Amikacintranslation

1.046

Cap5-10ug/mL Capreomycintranslation

0.305

Rox10-50 ug/mL Roxithromycintranslation

0.531

SM2-5 ug/mL Streptomycintranslation

-0.890

Tet5-10 ug/mL Tetracyclinetranslation

-1.201

Rif0.2-5ug/mL Rifampicintranscription

-0.420

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.265

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.071

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.765

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.114

Clofazimine10-13 ug/mL Clofaziminerespiration

0.811

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.356

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.224

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.320

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.666

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.220

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.204

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.729

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.164

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.677

KCN5-20 ug/mL Potassium cyaniderespiration

0.168

NaN30.2-2 mM Sodium aziderespiration

1.159

Nigericin50 uM Nigericinrespiration

-1.740

TRC10-150 ug/mL Triclosanrespiration

-1.803

TRZ10-25 ug/mL Thioridazinerespiration

0.101

Valinomycin0.5-10 uM Valinomycinrespiration

1.527

ZnSO42 mM ZnSO4respiration

0.196

menadione6-10 ug/mL Menadionerespiration

-0.298

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.748

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.050

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.852

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.697

NRP_1Non-replicating persistence stage 1dosRassociated

0.808

Amp0.2mg/mL AmpicillincellWall

0.580

Cephalexin20-100 ug/mL CephalexincellWall

0.879

Cerulenin0.32-5 ug/mL CerulenincellWall

0.395

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.431

EMB10-20 ug/mL EthambutolcellWall

0.211

Eta12-40 ug/mL EthionamidecellWall

-0.085

INH0.2-0.4 ug/mL IsoniazidcellWall

0.233

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.586

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.787

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.143

BZA0.12 mg/mL BenzamidearomaticAmides

-0.023

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.154

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.150

H2O24 mM hydrogen peroxideDNAdamaging

0.160

Levo10 ug/mL LevofloxacinDNAdamaging

0.715

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.773

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.909

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.791

UVUV-irradiationDNAdamaging

-0.611

ARP41-4 ug/mL Antitubercular compound ARP4?

0.524

Antimycin12.5-50 ug/mL Antimycin A?

1.158

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.438

PA_110-50 ug/mL Antitubercular compound PA-1?

0.618

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.511

PA8240.2-2 ug/mL PA-824?

-1.011

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.098

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.734

Verapamil50 uM Verapamil?

1.425

mercaptoethanol2 mM 2-Mercaptoethanol?

1.022

methoxatin10-20 ug/mL Methoxatin?